US-UK Pharmaceutical Pricing Deal: Ending Unfair Trade Practices

The United States and the United Kingdom have struck a major deal on pharmaceutical pricing, aiming to end Americans paying the highest drug prices globally. This agreement, announced by U.S. government departments, will see the UK increase its net price for new medicines by 25% and reduce certain rebate mechanisms. In return, the U.S. will exempt UK-made pharmaceuticals from certain tariffs. This deal is seen as a win for American workers and the innovation economy, potentially fueling U.S. research and manufacturing jobs, and serving as a model for future negotiations with other allies. The Daily News Now! - Every city. Every story. AI Powered. Hosted on Acast. See acast.com/privacy for more information.